Arab Journal of Gastroenterology
Volume 10, Issue 2 , Pages 68-71 , June 2009

Protective immunity after hepatitis B vaccination

  • Ayman Eldesoky

      Affiliations

    • Internal Medicine Department, Mansoura Faculty of Medicine, Mansoura, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 50 2293448/+20 50 9802279, Mobile: +20 125147601.
    • ,
  • Youssef Mosaad

      Affiliations

    • Clinical Immunology Unit, Clinical Pathology Department, Mansoura Faculty of Medicine, Mansoura, Egypt
    • ,
  • Yahia Zakria

      Affiliations

    • Internal Medicine Department, Mansoura Faculty of Medicine, Mansoura, Egypt
    • ,
  • Samah Hamdy

      Affiliations

    • Internal Medicine Department, Mansoura Faculty of Medicine, Mansoura, Egypt

Received 17 May 2009 ,Accepted 17 May 2009.

References 

  1. Chen CJ, You SL, Lin LH, et al. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32(Suppl):S66–S81
  2. Zuckerman JN. Protective efficacy, immunotherapeutic potential and safety of hepatitis B vaccines. J Med Virol. 2006;78(2):169–177
  3. Shih HH, Chang MH, Hsu HY, et al. Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan. Pediatr Infect Dis J. 1999;18(5):427–432
  4. Lee C, Gong Y, Brok J, et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006;332(7537):328–336
  5. Catania G, Di Ciommo V, Concato C. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital. Recent Prog Med. 1996;87(6):271–274
  6. Cassidy WM. Adolescent hepatitis B vaccination. A review. Minerva Pediatr. 2001;53(6):559–566
  7. Jafarzadeh A, Shokri F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates. Clin Exp Immunol. 2003;131(3):451–456
  8. Goldfarb J, Baley J, Medendorp SV, et al. Comparative study of the immunogenicity and safety of two dosing schedules of engerix-B hepatitis B vaccine in neonates. Pediatr Infect Dis J. 1994;13(1):18–22
  9. El Sawy IH, Mohamed ON. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children. East Mediterr Health J. 1999;5(5):922–932
  10. Amini S, Andalibi S, Mahmoodi M. Anti-HBs response and its protective effect in children and adults receiving HB recombinant vaccine in Tehran. Iran Med J Med Sci. 2002;27(3):101–105
  11. El-Marsafy EMK. Prevalence of hepatitis “B” antigens and antibodies in Egyptian infants and children [dissertation]. Faculty of Medicine, Cairo University; 1985.
  12. Reda AA, Arafa MA, Youssry AA, et al. Epidemiologic evaluation of the immunity against hepatitis B in Alexandria, Egypt. Eur J Epidemiol. 2003;18(10):1007–1011
  13. Barash C, Conn MI, DiMarino AJ, et al. Serologic hepatitis B immunity in vaccinated health care workers. Arch Int Med. 1999;159(13):1481–1483
  14. Williams JL, Christensen CJ, McMahon BJ, et al. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine. 2001;19(28–29):4081–4085
  15. Wu JS, Hwang LY, Goodman KJ, et al. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis. 1999;179(6):1319–1325
  16. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Int Med. 2001;135(9):796–800
  17. Zuckerman JN. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol. 1996;50(4):283–288
  18. Dentinger CM, McMahon BJ, Butler JC, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J. 2005;24(9):786–792
  19. Bulkow LR, Wainwright RB, McMahon BJ, et al. Increases in levels of antibody to hepatitis B surface antigen in an immunized population. Clin Infect Dis. 1998;26(4):933–937
  20. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986;315(4):209–214
  21. Madaliński K, Mikołajewicz J, Michalska Z. Vaccination against hepatitis B. Przegl Epidemiol. 1996;50(1–2):3–14
  22. Marhoffer W, Stein M, Schleinkofer L, et al. Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Res Clin Pract. 1993;19(3):183–188
  23. Wang LY, Lin HH. Ethnicity, substance use and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. J Hepatol. 2007;46(6):1018–1025

PII: S1687-1979(09)00010-0

doi: 10.1016/j.ajg.2009.05.002

Arab Journal of Gastroenterology
Volume 10, Issue 2 , Pages 68-71 , June 2009

Article Tools

* Image Usage & Resolution